2018 SUO Annual Meeting
SUO 2018 Prostate Cancer
- SUO 2018: PSMA-Guided Salvage Lymph Node Dissection
- SUO 2018: PROTUX Clinical Trial: Rituximab Neoadjuvant Therapy in High Risk Prostate Cancer Patients Scheduled to Undergo Radical Prostatectomy
- SUO 2018: Gene Expression Classifier Utility in Men at High Risk of Recurrence Following Radical Prostatectomy (G-MINOR)
- SUO 2018: Pathologic Progression is the Dominant Driver of Conversion to Radical Therapy Post Vascular
- SUO 2018: Lithium Treatment Alters Histone Lysine Modification in Prostate Cancers
SUO 2018 Bladder Cancer
- SUO 2018: An Oncolytic Adenovirus, for BCG-unresponsive Non-muscle-invasive Bladder Cancer (NMIBC): 18-month Follow-up from a Multicenter Phase II Trial
- SUO 2018: Before and After Clinical CR from NAC
- SUO 2018: Phase 2 Study of Pembrolizumab Monotherapy for High-Risk, Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG): Results from Keynote-057
- SUO 2018: Preclinical Models in Bladder Cancer and Translational Research
- SUO 2018: The Case for Neoadjuvant Immunotherapy
SUO 2018 Kidney Cancer
- SUO 2018: Debate: Enucleo-Resection vs. Wedge Resection for Partial Nephrectomy in 4 cm tumors - CON
- SUO 2018: Debate: Enucleo-Resection vs. Wedge Resection for Partial Nephrectomy in 4 cm tumors - PRO
- SUO 2018: Hereditary Kidney Cancer and Genetic Testing
- SUO 2018: Cytoreductive Nephrectomy Is No Longer Standard of Care in Patients with Metastatic Renal Cell Carcinoma
- SUO 2018: Surgical Perspective on Management for Hereditary Kidney Cancer